Are manufacturers sharing data as promised?

BMJ (Online)

Volumn 351, Issue , 2015, Pages

  Mayo Wilson, Evan ^a   Doshi, Peter ^b   Dickersin, Kay ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; CLINICAL DATA REPOSITORY; DRUG MANUFACTURE; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; PRIORITY JOURNAL; PUBLICATION; CLINICAL TRIAL (TOPIC); DRUG INDUSTRY; ETHICS; INFORMATION DISSEMINATION; RESEARCH ETHICS; STATISTICS AND NUMERICAL DATA;

CLINICAL TRIALS AS TOPIC; DRUG INDUSTRY; ETHICS, RESEARCH; INFORMATION DISSEMINATION;

EID: 84947283691     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h4169     Document Type: Article

References (15)

1. Doshi P. From promises to policies: is big pharma delivering on transparency? BMJ 2014;348:g1615.
2. Strom BL, Buyse M, Hughes J, Knoppers BM. Data sharing, year 1-access to data from industry-sponsored clinical trials. N Engl J Med 2014;371:2052-4.
3. Ebrahim S, Sohani ZN, Montoya L, et al. Reanalyses of randomized clinical trial data. JAMA 2014;312:1024-32.
4. AstraZeneca. Transparency of trial information. 2015 (accessed 27 Mar 2015; archived at http://bit.ly/1TpjRBG).
5. AstraZeneca. Disclosure commitment. 2015. http://astrazenecagrouptrials.pharmacm.com/Submission/Disclosure.
6. Institute of Medicine. Sharing clinical trial data: maximizing benefits, minimizing risk. 2015.
7. AstraZeneca. AstraZeneca establishes scientific review board to support clinical trial data transparency commitment [press release]. www.astrazeneca.com/Research/news/Article/20150319-astrazeneca-establishes-scientific-review-board.
8. Moorthy VS, Karam G, Vannice KS, Kienny MP. Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results. PLoS Med 2015;12:e1001819.
9. World Health Organization. WHO statement on public disclosure of clinical trial results. www.who.int/ictrp/results/reporting/en. 2015.
10. Drazen JM. Sharing individual patient data from clinical trials. N Engl J Med 2015;372:201-2.
11. Hughes S, Wells K, McSorley P, Freeman A. Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach. Pharm Stat 2014;13:179-83.
12. Chalmers I, Bracken MB, Djulbegovic B, et al. How to increase value and reduce waste when research priorities are set. Lancet 2014;383:156-65.
13. Chan AW, Song F, Vickers A, et al. Increasing value and reducing waste: addressing inaccessible research. Lancet 2014;383:257-66.
14. Goodman S, Dickersin K. Metabias: a challenge for comparative effectiveness research. Ann Intern Med 2011;155:61-2.
15. Song F, Parekh S, Hooper L, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technology Assess 2010;14:iii, ix-xi, 1-193.